DE69738977D1 - Neues fusionsprotein, dafuer kodierendes gen, rekoerwendung - Google Patents

Neues fusionsprotein, dafuer kodierendes gen, rekoerwendung

Info

Publication number
DE69738977D1
DE69738977D1 DE69738977T DE69738977T DE69738977D1 DE 69738977 D1 DE69738977 D1 DE 69738977D1 DE 69738977 T DE69738977 T DE 69738977T DE 69738977 T DE69738977 T DE 69738977T DE 69738977 D1 DE69738977 D1 DE 69738977D1
Authority
DE
Germany
Prior art keywords
dafuer
fusion protein
encoding gene
new fusion
rebate application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69738977T
Other languages
English (en)
Inventor
Shuji Saito
Yoshinari Tsuzaki
Noboru Yanagida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Original Assignee
Zeon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeon Corp filed Critical Zeon Corp
Application granted granted Critical
Publication of DE69738977D1 publication Critical patent/DE69738977D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24041Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69738977T 1996-03-29 1997-03-28 Neues fusionsprotein, dafuer kodierendes gen, rekoerwendung Expired - Fee Related DE69738977D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10354896 1996-03-29
PCT/JP1997/001084 WO1997036924A1 (fr) 1996-03-29 1997-03-28 Nouvelle proteine fusionnee, gene s'y rapportant, vecteur recombinant, virus recombinant et leur utilisation

Publications (1)

Publication Number Publication Date
DE69738977D1 true DE69738977D1 (de) 2008-10-23

Family

ID=14356886

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738977T Expired - Fee Related DE69738977D1 (de) 1996-03-29 1997-03-28 Neues fusionsprotein, dafuer kodierendes gen, rekoerwendung

Country Status (7)

Country Link
US (1) US7348422B2 (de)
EP (1) EP0905140B9 (de)
JP (1) JP3357071B2 (de)
AU (1) AU2176997A (de)
DE (1) DE69738977D1 (de)
ES (1) ES2309996T3 (de)
WO (1) WO1997036924A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60136356D1 (de) * 2000-06-12 2008-12-11 Univ Saskatchewan Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik
US20030059799A1 (en) * 2001-07-11 2003-03-27 Takashi Okuda Modified DNA molecule, recombinant containing the same, and uses thereof
US6936707B2 (en) 2001-07-11 2005-08-30 Zeon Corporation Modified DNA molecule, recombinant containing the same, and uses thereof
CN105567648B (zh) 2009-04-15 2019-09-03 法国诗华大药厂 用于免疫接种水禽物种的重组禽疱疹病毒载体和疫苗
EP2789346A1 (de) 2013-04-11 2014-10-15 CEVA Santé Animale SA Fusionspolypeptide und Impfstoffe

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286639A (en) 1987-09-16 1994-02-15 Nippon Zeon Co., Ltd. Recombinant avipoxvirus
CA1339260C (en) * 1988-06-02 1997-08-12 Kazumi Kodama Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
JP2781605B2 (ja) * 1989-06-22 1998-07-30 日本ゼオン株式会社 組み換えアビポックスウイルス
GB8915870D0 (en) * 1989-07-11 1989-08-31 Nat Res Dev Dna coding for a polypeptide signal sequence in vaccinia virus
PT623172E (pt) * 1992-01-13 2005-02-28 Virogenetics Corp Vacina de virus vaccinia recombinante do virus da doenca de marek
DE69435169D1 (de) 1993-03-31 2009-01-02 Zeon Corp Polypeptid, dafür kodierende DNA, diese DNA beinhaltender, rekombinanter Vektor, Herstellung eines rekombinanten Virus unter Verwendung dieses Vektors und dessen Anwendung

Also Published As

Publication number Publication date
US7348422B2 (en) 2008-03-25
US20010014335A1 (en) 2001-08-16
WO1997036924A1 (fr) 1997-10-09
ES2309996T3 (es) 2008-12-16
EP0905140A4 (de) 2000-12-06
JP3357071B2 (ja) 2002-12-16
AU2176997A (en) 1997-10-22
EP0905140B1 (de) 2008-09-10
EP0905140B9 (de) 2009-05-13
EP0905140A1 (de) 1999-03-31

Similar Documents

Publication Publication Date Title
DK1490386T3 (da) Nyt polypeptid og nukleinsyrer kodende for dette
IS8368A (is) Ný aðferð
NO20002990L (no) Nytt overflateprotein
DE69913344D1 (de) Kodierung von spritzeninformation
DE69833228D1 (de) Brückenzünder
DE69817460D1 (de) Bildsequenzdekodierungsverfahren
ID24289A (id) Benzotiazol inhibitor-inhibitor protein terosin kinase
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
NO2010013I1 (no) Rekombinant FSH-CTP
DK0917879T3 (da) Forbedret fremgangsmåde til stabilisering af proteiner
ATE451466T1 (de) Rekombinanter rhabdovirus, welcher ein heterologes fusionsprotein enthält
DE59902358D1 (de) Halbbrückenbaugruppe
IS5106A (is) Ný aðferð
MX219629B (es) Metodo para separar proteinas de fusion
DE69705017T2 (de) Medikamente bindendes Protein
NO995062D0 (no) <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som kodes for samme
DE69738977D1 (de) Neues fusionsprotein, dafuer kodierendes gen, rekoerwendung
DE69823225D1 (de) Fusionsproteine, bestehend aus proteinaseinhibitoren
DK1036014T3 (da) Afstandsholder
DE69925271D1 (de) Angiostatin-bindendes protein
GB2332906A8 (en) Nucleic acids encoding TTX-resistant Na channel proteins
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
BR9408061A (pt) Sequência de dna codificando carboxipeptidase b pancreática de suiínos
EP0970192A4 (de) Nukleinsäure, die für das algu protein von m. tuberculosis kodiert.
NO20021614L (no) DNA som koder for PROST 07-polypeptid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee